-
1
-
-
74349113853
-
A novel approach to cancer staging: Application to esophageal cancer
-
Ishwaran H, Blackstone EH, Apperson-Hansen C, et al. A novel approach to cancer staging: application to esophageal cancer. Biostatistics 2009; 10: 603-20.
-
(2009)
Biostatistics
, vol.10
, pp. 603-620
-
-
Ishwaran, H.1
Blackstone, E.H.2
Apperson-Hansen, C.3
-
2
-
-
33644796262
-
Current and ongoing progress in the therapy for resectable esophageal cancer
-
Thomas CR, Jr,. Current and ongoing progress in the therapy for resectable esophageal cancer. Dis Esophagus 2005; 18: 211-14.
-
(2005)
Dis Esophagus
, vol.18
, pp. 211-214
-
-
Thomas, Jr.C.R.1
-
3
-
-
33847156303
-
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis
-
Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007; 8: 226-34.
-
(2007)
Lancet Oncol
, vol.8
, pp. 226-234
-
-
Gebski, V.1
Burmeister, B.2
Smithers, B.M.3
-
4
-
-
79959572435
-
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: An updated meta-analysis
-
Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 2011; 12: 681-92.
-
(2011)
Lancet Oncol
, vol.12
, pp. 681-692
-
-
Sjoquist, K.M.1
Burmeister, B.H.2
Smithers, B.M.3
-
5
-
-
27644561794
-
Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: Implications for response classification
-
Schneider PM, Baldus SE, Metzger R, et al. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg 2005; 242: 684-92.
-
(2005)
Ann Surg
, vol.242
, pp. 684-692
-
-
Schneider, P.M.1
Baldus, S.E.2
Metzger, R.3
-
6
-
-
60549115069
-
Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis
-
Bollschweiler E, Metzger R, Drebber U, et al. Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis. Ann Oncol 2009; 20: 231-8.
-
(2009)
Ann Oncol
, vol.20
, pp. 231-238
-
-
Bollschweiler, E.1
Metzger, R.2
Drebber, U.3
-
7
-
-
78349276148
-
A multicenter study of survival after neoadjuvant radiotherapy/ chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer
-
Vallbohmer D, Holscher AH, DeMeester S, et al. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer. Ann Surg 2010; 252: 744-9.
-
(2010)
Ann Surg
, vol.252
, pp. 744-749
-
-
Vallbohmer, D.1
Holscher, A.H.2
Demeester, S.3
-
8
-
-
75149144082
-
Histologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancer
-
Bollschweiler E, Holscher AH, Metzger R,. Histologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancer. Future Oncol 2010; 6: 25-35.
-
(2010)
Future Oncol
, vol.6
, pp. 25-35
-
-
Bollschweiler, E.1
Holscher, A.H.2
Metzger, R.3
-
9
-
-
58149402944
-
Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer
-
Schneider PM, Metzger R, Schaefer H, et al. Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer. Ann Surg 2008; 248: 902-8.
-
(2008)
Ann Surg
, vol.248
, pp. 902-908
-
-
Schneider, P.M.1
Metzger, R.2
Schaefer, H.3
-
10
-
-
33748706965
-
Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET
-
Sloof GW,. Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET. Best Pract Res Clin Gastroenterol 2006; 20: 941-57.
-
(2006)
Best Pract Res Clin Gastroenterol
, vol.20
, pp. 941-957
-
-
Sloof, G.W.1
-
11
-
-
73449136130
-
[18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer
-
Vallbohmer D, Holscher AH, Dietlein M, et al. [18F]-Fluorodeoxyglucose- positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer. Ann Surg 2009; 250: 888-94.
-
(2009)
Ann Surg
, vol.250
, pp. 888-894
-
-
Vallbohmer, D.1
Holscher, A.H.2
Dietlein, M.3
-
12
-
-
78751627736
-
Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer
-
van Heijl M, Omloo JM, van Berge Henegouwen MI, et al. Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer. Ann Surg 2011; 253: 56-63.
-
(2011)
Ann Surg
, vol.253
, pp. 56-63
-
-
Van Heijl, M.1
Omloo, J.M.2
Van Berge Henegouwen, M.I.3
-
13
-
-
36348960122
-
Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer
-
Duong C, Greenawalt DM, Kowalczyk A, et al. Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer. Ann Surg Oncol 2007; 14: 3602-9.
-
(2007)
Ann Surg Oncol
, vol.14
, pp. 3602-3609
-
-
Duong, C.1
Greenawalt, D.M.2
Kowalczyk, A.3
-
14
-
-
70449440737
-
Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer
-
Maher SG, Gillham CM, Duggan SP, et al. Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer. Ann Surg 2009; 250: 729-37.
-
(2009)
Ann Surg
, vol.250
, pp. 729-737
-
-
Maher, S.G.1
Gillham, C.M.2
Duggan, S.P.3
-
15
-
-
74949101064
-
Microarray-based response prediction in esophageal adenocarcinoma
-
Schauer M, Janssen KP, Rimkus C, et al. Microarray-based response prediction in esophageal adenocarcinoma. Clin Cancer Res 2010; 16: 330-7.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 330-337
-
-
Schauer, M.1
Janssen, K.P.2
Rimkus, C.3
-
16
-
-
84876718945
-
MicroRNAs and esophageal cancer - Implications for pathogenesis and therapy
-
Mayne GC, Hussey DJ, Watson DI,. microRNAs and esophageal cancer-implications for pathogenesis and therapy. Curr Pharm Des 2013; 19: 1211-26.
-
(2013)
Curr Pharm des
, vol.19
, pp. 1211-1226
-
-
Mayne, G.C.1
Hussey, D.J.2
Watson, D.I.3
-
17
-
-
67349106718
-
Small RNA: A large contributor to carcinogenesis?
-
Bhatti I, Lee A, Lund J, et al. Small RNA: a large contributor to carcinogenesis? J Gastrointest Surg 2009; 13: 1379-88.
-
(2009)
J Gastrointest Surg
, vol.13
, pp. 1379-1388
-
-
Bhatti, I.1
Lee, A.2
Lund, J.3
-
18
-
-
39149100654
-
Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma
-
Guo Y, Chen Z, Zhang L, et al. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 2008; 68: 26-33.
-
(2008)
Cancer Res
, vol.68
, pp. 26-33
-
-
Guo, Y.1
Chen, Z.2
Zhang, L.3
-
19
-
-
78349253777
-
Prognostic significance of differentially expressed miRNAs in esophageal cancer
-
Hu Y, Correa AM, Hoque A, et al. Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int J Cancer 2011; 128: 132-43.
-
(2011)
Int J Cancer
, vol.128
, pp. 132-143
-
-
Hu, Y.1
Correa, A.M.2
Hoque, A.3
-
20
-
-
70349662168
-
MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: Associations with survival
-
Mathe EA, Nguyen GH, Bowman ED, et al. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 2009; 15: 6192-200.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 6192-6200
-
-
Mathe, E.A.1
Nguyen, G.H.2
Bowman, E.D.3
-
21
-
-
67650664984
-
Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR
-
Ogawa R, Ishiguro H, Kuwabara Y, et al. Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med Mol Morphol 2009; 42: 102-9.
-
(2009)
Med Mol Morphol
, vol.42
, pp. 102-109
-
-
Ogawa, R.1
Ishiguro, H.2
Kuwabara, Y.3
-
22
-
-
33846258745
-
RNASEN regulates cell proliferation and affects survival in esophageal cancer patients
-
Sugito N, Ishiguro H, Kuwabara Y, et al. RNASEN regulates cell proliferation and affects survival in esophageal cancer patients. Clin Cancer Res 2006; 12: 7322-8.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 7322-7328
-
-
Sugito, N.1
Ishiguro, H.2
Kuwabara, Y.3
-
23
-
-
80052971458
-
Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma
-
Akagi I, Miyashita M, Ishibashi O, et al. Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma. Dis Esophagus 2011; 24: 523-30.
-
(2011)
Dis Esophagus
, vol.24
, pp. 523-530
-
-
Akagi, I.1
Miyashita, M.2
Ishibashi, O.3
-
24
-
-
79955375953
-
MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma
-
Feber A, Xi L, Pennathur A, et al. MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma. Ann Thorac Surg 2011; 91: 1523-30.
-
(2011)
Ann Thorac Surg
, vol.91
, pp. 1523-1530
-
-
Feber, A.1
Xi, L.2
Pennathur, A.3
-
25
-
-
78651356009
-
MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma
-
Hummel R, Hussey DJ, Michael MZ, et al. MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma. Ann Surg Oncol 2011; 18: 253-60.
-
(2011)
Ann Surg Oncol
, vol.18
, pp. 253-260
-
-
Hummel, R.1
Hussey, D.J.2
Michael, M.Z.3
-
26
-
-
78651507625
-
MiRNA profile in esophageal squamous cell carcinoma: Downregulation of miR-143 and miR-145
-
Wu BL, Xu LY, Du ZP, et al. MiRNA profile in esophageal squamous cell carcinoma: downregulation of miR-143 and miR-145. World J Gastroenterol 2011; 17: 79-88.
-
(2011)
World J Gastroenterol
, vol.17
, pp. 79-88
-
-
Wu, B.L.1
Xu, L.Y.2
Du, Z.P.3
-
27
-
-
79955519053
-
Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway
-
Hamano R, Miyata H, Yamasaki M, et al. Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway. Clin Cancer Res 2011; 17: 3029-38.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 3029-3038
-
-
Hamano, R.1
Miyata, H.2
Yamasaki, M.3
-
28
-
-
77953020454
-
The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma
-
Hong L, Han Y, Zhang H, et al. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Ann Surg 2010; 251: 1056-63.
-
(2010)
Ann Surg
, vol.251
, pp. 1056-1063
-
-
Hong, L.1
Han, Y.2
Zhang, H.3
-
29
-
-
79960781245
-
Chemotherapy-induced modification of microRNA expression in esophageal cancer
-
Hummel R, Wang T, Watson DI, et al. Chemotherapy-induced modification of microRNA expression in esophageal cancer. Oncol Rep 2011; 26: 1011-17.
-
(2011)
Oncol Rep
, vol.26
, pp. 1011-1017
-
-
Hummel, R.1
Wang, T.2
Watson, D.I.3
-
30
-
-
84866670215
-
MicroRNA expression profiling of esophageal cancer before and after induction chemoradiotherapy
-
Ko MA, Zehong G, Virtanen C, et al. MicroRNA expression profiling of esophageal cancer before and after induction chemoradiotherapy. Ann Thorac Surg 2012; 94: 1094-102.
-
(2012)
Ann Thorac Surg
, vol.94
, pp. 1094-1102
-
-
Ko, M.A.1
Zehong, G.2
Virtanen, C.3
-
31
-
-
84863912807
-
-
7th edn. Oxford, UK: Wiley-Blackwell
-
Sobin LH, Gospodarowicz MK, Wittekind C,. TNM classification of malignant tumours, 7th edn. Oxford, UK: Wiley-Blackwell, 2009.
-
(2009)
TNM Classification of Malignant Tumours
-
-
Sobin, L.H.1
Gospodarowicz, M.K.2
Wittekind, C.3
-
32
-
-
33846426446
-
Laparoscopic ischemic conditioning of the stomach for esophageal replacement
-
Holscher AH, Schneider PM, Gutschow C, et al. Laparoscopic ischemic conditioning of the stomach for esophageal replacement. Ann Surg 2007; 245: 241-6.
-
(2007)
Ann Surg
, vol.245
, pp. 241-246
-
-
Holscher, A.H.1
Schneider, P.M.2
Gutschow, C.3
-
33
-
-
77952424611
-
Ivor-Lewis esophagectomy with and without laparoscopic conditioning of the gastric conduit
-
Schroder W, Holscher AH, Bludau M, et al. Ivor-Lewis esophagectomy with and without laparoscopic conditioning of the gastric conduit. World J Surg 2010; 34: 738-43.
-
(2010)
World J Surg
, vol.34
, pp. 738-743
-
-
Schroder, W.1
Holscher, A.H.2
Bludau, M.3
-
34
-
-
58349108273
-
Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR
-
Siebolts U, Varnholt H, Drebber U, et al. Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR. J Clin Pathol 2009; 62: 84-8.
-
(2009)
J Clin Pathol
, vol.62
, pp. 84-88
-
-
Siebolts, U.1
Varnholt, H.2
Drebber, U.3
-
35
-
-
0027457620
-
Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine
-
Zweig MH, Campbell G,. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-77.
-
(1993)
Clin Chem
, vol.39
, pp. 561-577
-
-
Zweig, M.H.1
Campbell, G.2
-
36
-
-
79952067801
-
Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells
-
Hummel R, Watson DI, Smith C, et al. Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells. J Gastrointest Surg 2011; 15: 429-38.
-
(2011)
J Gastrointest Surg
, vol.15
, pp. 429-438
-
-
Hummel, R.1
Watson, D.I.2
Smith, C.3
-
37
-
-
84875821441
-
MicroRNA-145 in Barrett's oesophagus: Regulating BMP4 signalling via GATA6
-
van Baal J, Verbeek R, Bus P, et al. microRNA-145 in Barrett's oesophagus: regulating BMP4 signalling via GATA6. Gut 2013; 62: 664-75.
-
(2013)
Gut
, vol.62
, pp. 664-675
-
-
Van Baal, J.1
Verbeek, R.2
Bus, P.3
-
38
-
-
58149340662
-
MiR-192 regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit
-
Song B, Wang Y, Kudo K, et al. miR-192 regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clin Cancer Res 2008; 14: 8080-6.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 8080-8086
-
-
Song, B.1
Wang, Y.2
Kudo, K.3
-
39
-
-
77955478900
-
MiR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation
-
Boni V, Bitarte N, Cristobal I, et al. miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation. Mol Cancer Ther 2010; 9: 2265-75.
-
(2010)
Mol Cancer Ther
, vol.9
, pp. 2265-2275
-
-
Boni, V.1
Bitarte, N.2
Cristobal, I.3
-
40
-
-
84859460629
-
MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response
-
Wang W, Corrigan-Cummins M, Hudson J, et al. MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response. Haematologica 2012; 97: 586-94.
-
(2012)
Haematologica
, vol.97
, pp. 586-594
-
-
Wang, W.1
Corrigan-Cummins, M.2
Hudson, J.3
|